-
Sector Analysis
Generalized Pustular Psoriasis (GPP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Generalized Pustular Psoriasis Marketed and Pipeline Drugs Report Overview By 2028, GlobalData estimates that the highest prevalence of GPP cases will be in South Korea and China. Generalized Pustular Psoriasis (GPP) is a subtype of psoriasis in which patients exhibit painful episodes of sterile pustules in their skin. Companies such as AbbVie and academic institutions both are investing heavily in the the clinical trials for GPP. Key Mechanism of Action (Marketed) ·       Receptor Agonist ·       Biological Factor Inhibitor ·       Receptor...
-
Product Insights
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cutaneous Lupus Erythematosus Clinical Trials Overview The Cutaneous Lupus Erythematosus clinical trial report consists of 138 trials. The report provides an overview of the Cutaneous Lupus Erythematosus clinical trials scenario. The report provides top-line data relating to the clinical trials on Cutaneous Lupus Erythematosus. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
Hereditary Angioedema Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Hereditary Angioedema Clinical Trials Market Report Overview There were a total of 204 hereditary angioedema clinical trials conducted as of January 2023. The hereditary angioedema (hae) (c1 esterase inhibitor [c1-inh] deficiency) clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials...
-
Sector Analysis
EpiCast Report: Systemic Lupus Erythematosus (SLE) – Epidemiology Forecast to 2025
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ system, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Because of its dynamic nature, this disease has an unpredictable natural course leading to high rates of morbidity and even death. The incidence and prevalence of SLE varies globally and the variation is attributed to a combination of elements...
-
Product Insights
Osteoarthritis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Psoriasis – 5EU Drug Forecast and Market Analysis to 2024
Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for patients. GlobalData projects the Psoriasis market in 8MM to experience modest growth during the forecast period at a CAGR of 7.26%. This growth will be driven primarily by the highly anticipated arrivals of promising...
-
Product Insights
Bone Marrow Transplant Rejection Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bone Marrow Transplant Rejection Global Clinical Trials Review, H1, 2017" provides an overview of Bone Marrow Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Marrow Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cat Allergy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cat Allergy Global Clinical Trials Review, H1, 2017" provides an overview of Cat Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cat Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cedar Pollen Allergy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cedar Pollen Allergy Global Clinical Trials Review, H1, 2017" provides an overview of Cedar Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cedar Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.